Saltar a Buscador
Saltar a menú servicios
Saltar a Noticias y Convocatorias - Menú principal. Secciones - - Fin de Menú principal -
- Título de la Sección Seleccionada -
- TÃtulo de la Sección Seleccionada -
- Información de interés -
- Fin de Información de interés -
- Información principal -
Recent News
03/09/2010
Gene profiles may predict TB prognosisThanks to molecular profiling, scientists now have a better idea about how a mass killer selects its victims. And the new analysis suggests that the killer, TB, may use a different murder weapon than researchers previously believed. ScienceNews |
03/09/2010
Stem-cell work thrown into limboUS district-court ruling suspends federal funding for research involving human embryonic stem cells. naturenews |
16/07/2010
Antiaging protein also boosts learning and memoryResearch in mice suggests additional role for sirtuins ScienceNews |
16/07/2010
Animal sperm arose onceGene for male reproductive cells traced back 600 million years ScienceNews |
01/07/2010
Boston University researchers identify genetic signatures of human exceptional longevityWhile environment and family history are factors in healthy aging, genetic variants play a critical and complex role in conferring exceptional longevity, according to a new study by a team of researchers from the Boston University Schools of Public Health and Medicine and the Boston Medical Center. Science |
25/06/2010
Genetically Altered Salmon Get Closer to the TableThe Food and Drug Administration is seriously considering whether to approve the first genetically engineered animal that people would eat — salmon that can grow at twice the normal rate. The New York Times |
24/06/2010
Making lungs in the labBiomedical engineers have built many types of human organs in the lab, but they've lagged on lung tissue — until now. Two new studies have used very different approaches to do the job. Nature |
22/06/2010
NIH rejects use of dozens of stem cell colonies by federally funded researchersThe National Institutes of Health (NIH) rejected a request to approve dozens of colonies of human embryonic stem cells for use by federally funded researchers. Scientists had been hoping the lines would become available for their research under a new policy from the Obama administration. The Washington Post |
21/06/2010
FDA approves a more advanced HIV test by Abbott LabsThe U.S. Food and Drug Administration (FDA) has approved Abbott Laboratories Inc test, which may help slow the spread of HIV by detecting the virus in the earlier stages when it is most infectious. Reuters |
21/06/2010
Scientists map the genome of the human body louseResearchers report that they have sequenced the genome of the human body louse (Pediculus humanus humanus). Associated Press |
19/06/2010
FDA pushes orphan drug researchRoche Holding's hepatitis drug and Biogen Idec's multiple sclerosis treatment are among the FDA-approved medicines that the agency suggested for orphan-drug research. The Boston Globe |
18/06/2010
Orphan Medicines in Europe. 10 years on, we ask: did it work?10 years ago, the European Parliament unanimously endorsed a law to stimulate the development of treatments for rare disease patients in the EU. EuropaBio |
18/06/2010
German drugs' guardian rejects GSK's Avandia pillA German drugs' protector announced insurance companies stop paying for GlaxoSmithKline's (GSK) Avandia, a controversial diabetes pill. Reuters |
17/06/2010
Gene Therapy for HIV Inches ForwardResearchers report they've moved a step closer to treating HIV patients with gene therapy that could potentially one day keep the AIDS-causing virus at bay. Bloomberg.com |
17/06/2010
Stem cell breakthrough for lung disease patientsA recent study has revealed that human cells isolated from the placenta could potentially heal lung injuries in patients. Cell Therapy News |
16/06/2010
Abbott Laboratories (ABT), Neurocrine Biosciences, Inc. (NBIX) inPact for Endometriosis Drug, Elagolix; Neurocrine to Get up to $575 MillionAbbott and Neurocrine Biosciences, Inc. (Nasdaq:NBIX - News) today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids. BioSpace.com |
16/06/2010
A physical model describes the structures of viral capsidsThe genetic material of viruses is shielded by a protective protein covering called a capsid. The UB researchers David Reguera and Antoni Luque, of the Department of Fundamental Physics, have uncovered the strict selection rules that define capsid structure in spherical and bacilliform viruses, which they report in two papers published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) and the Biophysical Journal. University of Barcelona |
15/06/2010
Protein extremes gain relevance in massive proteomic studiesResearchers at University of Ghent, Belgium, and Universitat Autònoma de Barcelona (UAB) develop a new procedure to identify the two extremes of protein molecules and their processing and maturing in in-vivo and ex-vivo massive proteomic studies. The research has been published online at Nature Methods, under the title of "Complementary Positional Proteomics for Screening of Endo- and Exoproteases". Universitat Autònoma de Barcelona |
12/06/2010
A Decade Later, Genetic Map Yields Few New CuresTen years after President Bill Clinton announced that the first draft of the human genome was complete, medicine has yet to see any large part of the promised benefits. The New York Times |
- Buscador -
- Menu de Servicios -
Services
- Últimas Noticias o Eventos -
Highlights
